| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A05715709 |
| PharmacoGx | BRD-A05715709 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RP11-434D12.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | SPG7 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | HPS3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | PLEKHH3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | PLPP2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | RSG1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | PKD1L3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | P2RY6 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | PARP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | AC011380.1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
